EMFAT
NEO icon

Emerald Mutual Fund Advisers Trust’s NeoGenomics NEO Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320K Sell
43,071
-1,848
-4% -$19.4K 0.02% 179
2025
Q4 		$528K Buy
+44,919
New +$485K 0.03% 157
2025
Q2 		– Sell
-654,281
Closed -$6.21M – 226
2025
Q1 		$6.21M Sell
654,281
-413,119
-39% -$5.16M 0.44% 82
2024
Q4 		$17.6M Sell
1,067,400
-166,165
-13% -$2.58M 1.07% 36
2024
Q3 		$18.2M Sell
1,233,565
-314,330
-20% -$4.92M 0.95% 40
2024
Q2 		$21.5M Sell
1,547,895
-10,000
-0.6% -$142K 1.12% 32
2024
Q1 		$24.5M Hold
1,557,895
– – 1.28% 19
2023
Q4 		$25.2M Hold
1,557,895
– – 1.33% 17
2023
Q3 		$19.2M Buy
1,557,895
+183,112
+13% +$2.72M 1.16% 23
2023
Q2 		$22.1M Hold
1,374,783
– – 1.2% 22
2023
Q1 		$23.9M Sell
1,374,783
-279,760
-17% -$3.99M 1.41% 13
2022
Q4 		$15.3M Buy
1,654,543
+886,357
+115% +$8.26M 0.95% 45
2022
Q3 		$6.61M Sell
768,186
-191,672
-20% -$1.9M 0.42% 83
2022
Q2 		$7.82M Sell
959,858
-974
-0.1% -$9.3K 0.45% 87
2022
Q1 		$11.7M Sell
960,832
-45,256
-4% -$952K 0.52% 75
2021
Q4 		$34.3M Buy
1,006,088
+7,230
+0.7% +$283K 1.21% 25
2021
Q3 		$48.2M Hold
998,858
– – 1.67% 9
2021
Q2 		$45.1M Sell
998,858
-190,654
-16% -$8.45M 1.48% 9
2021
Q1 		$57.4M Sell
1,189,512
-13,305
-1% -$693K 1.9% 2
2020
Q4 		$64.8M Sell
1,202,817
-106,851
-8% -$4.83M 2.25% 2
2020
Q3 		$48.3M Hold
1,309,668
– – 2.14% 4
2020
Q2 		$40.6M Buy
1,309,668
+114,653
+10% +$3.18M 1.92% 6
2020
Q1 		$33M Sell
1,195,015
-253,233
-17% -$7.59M 2.07% 4
2019
Q4 		$42.4M Sell
1,448,248
-330,282
-19% -$7.87M 1.73% 6
2019
Q3 		$34M Sell
1,778,530
-87,229
-5% -$2.05M 1.51% 11
2019
Q2 		$40.9M Sell
1,865,759
-10,000
-0.5% -$219K 1.63% 8
2019
Q1 		$38.4M Buy
1,875,759
+41,390
+2% +$719K 1.54% 6
2018
Q4 		$23.1M Buy
1,834,369
+277,624
+18% +$4.14M 1.08% 23
2018
Q3 		$23.9M Buy
1,556,745
+1,112,939
+251% +$15.4M 0.81% 34
2018
Q2 		$5.82M Buy
443,806
+161,300
+57% +$1.78M 0.21% 153
2018
Q1 		$2.31M Sell
282,506
-910,095
-76% -$7.37M 0.09% 192
2017
Q4 		$10.6M Buy
1,192,601
+75,046
+7% +$692K 0.42% 86
2017
Q3 		$12.4M Buy
1,117,555
+210,026
+23% +$2.04M 0.52% 68
2017
Q2 		$8.13M Hold
907,529
– – 0.35% 104
2017
Q1 		$7.16M Buy
907,529
+126,851
+16% +$1.03M 0.33% 109
2016
Q4 		$6.69M Buy
780,678
+147,089
+23% +$1.26M 0.32% 113
2016
Q3 		$5.21M Buy
633,589
+207,769
+49% +$1.74M 0.27% 122
2016
Q2 		$3.42M Buy
+425,820
New +$3.41M 0.19% 141

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's NEO Position: Q1 2026 in Review

Emerald Mutual Fund Advisers Trust reduced its NeoGenomics (NEO) stake by 4.1% in Q1 2026, selling an estimated $19.4K and leaving 43,071 shares worth $320K. The position accounts for 0.02% of the portfolio, ranked #179.

Emerald Mutual Fund Advisers Trust first reported a position in NEO in Q2 2016 and has held it in 38 quarters since. The position peaked at $64.8M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Emerald Mutual Fund Advisers Trust held 43,071 shares of NeoGenomics worth $320K as of Q1 2026.
  • Emerald Mutual Fund Advisers Trust sold 1,848 NeoGenomics shares in Q1 2026, an estimated $19.4K.
  • NeoGenomics made up 0.02% of Emerald Mutual Fund Advisers Trust's portfolio in Q1 2026, its #179 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in NeoGenomics in Q2 2016 and has held it in 38 quarters since.
  • Emerald Mutual Fund Advisers Trust's NeoGenomics position peaked at $64.8M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2026, filed 4 May 2026.